November 21, 2008Targanta shares dive 82% after drug is rejected - Boston Globe Targanta shares dive 82% after drug is rejected - Boston Globe
Shares of Targanta Therapeutics Corp. plummeted 82 percent yesterday, a day after the Cambridge biotechnology company failed to convince a federal advisory panel that its key product, an experimental antibiotic, should be approved. The Food and Drug Source: www.boston.com Glemnark recieves USFDA approval for Ranitidine tablets - Reuters India MUMBAI, Nov 21 (Reuters) - Glenmark Pharmaceuticals Ltd (GLEN.BO: Quote , Profile , Research ) received approval from the United States Food and Drug Administration for distribution and marketing of Ranitidine tablets in the U.S. market, it said in a Source: in.reuters.com # posted by Network @ 3:00 AM
 |
Subscribe to Posts [Atom]